Macrophage glucocorticoid receptors regulate toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase

被引:190
作者
Bhattacharyya, Sandip
Brown, Diane E.
Brewer, Judson A.
Vogt, Sherri K.
Muglia, Louis J.
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA
关键词
D O I
10.1182/blood-2006-10-048215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To explore the role of glucocorticoids in regulation of kinase pathways during innate immune responses, we generated mice with conditional deletion of glucocorticoid receptor (GR) in macrophages (MGRKO). Activation of toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS) caused greater mortality and cytokine production in MGRKO mice than in controls. Ex vivo, treatment with dexamethasone (Dex) markedly inhibited LPS-mediated induction of inflammatory genes in control but not GFI-deficient macrophages. We show that Dex inhibits p38 MAPK, but not PI3K/Akt, ERK or JNK, in control macrophages. Associated with p38 inhibition, Dex induced MAP kinase phosphatase-1 (MKP-1) in control, but not. MGRKO, macrophages. Consistent with the ex vivo studies, treatment with a p38 MAPK-specific inhibitor resulted in rescue of MGRKO mice from LPS-induced lethality. Taken together, we identify p38 MAPK and its downstream targets as essential for GR-mediated Immunosuppression in macrophages.
引用
收藏
页码:4313 / 4319
页数:7
相关论文
共 57 条
  • [31] Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κB and steroid receptor-signaling pathways
    McKay, LI
    Cidlowski, JA
    [J]. ENDOCRINE REVIEWS, 1999, 20 (04) : 435 - 459
  • [32] Innate immunity: The virtues of a nonclonal system of recognition
    Medzhitov, R
    Janeway, CA
    [J]. CELL, 1997, 91 (03) : 295 - 298
  • [33] Novel inhibitor of p38 MAP kinase as an anti-TNF-α drug:: Discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent
    Miwatashi, S
    Arikawa, Y
    Kotani, E
    Miyamoto, M
    Naruo, K
    Kimura, H
    Tanaka, T
    Asahi, S
    Ohkawa, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) : 5966 - 5979
  • [34] Subnuclear trafficking and gene targeting by steroid receptors
    Nagaich, AK
    Rayasam, GV
    Martinez, ED
    Becker, M
    Qiu, Y
    Johnson, TA
    Elbi, C
    Fletcher, TM
    John, S
    Hager, GL
    [J]. GLUCOCORTICOID ACTION: BASIC AND CLINICAL IMPLICATIONS, 2004, 1024 : 213 - 220
  • [35] Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model
    Nash, SP
    Heuertz, RM
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (13-14) : 1870 - 1880
  • [36] Points of control in inflammation
    Nathan, C
    [J]. NATURE, 2002, 420 (6917) : 846 - 852
  • [37] How Toll-like receptors signal: what we know and what we don't know
    O'Neill, LAJ
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) : 3 - 9
  • [38] Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
    Ogawa, S
    Lozach, J
    Benner, C
    Pascual, G
    Tangirala, RK
    Westin, S
    Hoffmann, A
    Subramaniam, S
    David, M
    Rosenfeld, MG
    Glass, CK
    [J]. CELL, 2005, 122 (05) : 707 - 721
  • [39] Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages
    Okugawa, S
    Ota, Y
    Kitazawa, T
    Nakayama, K
    Yanagimoto, S
    Tsukada, K
    Kawada, M
    Kimura, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (02): : C399 - C408
  • [40] Single-dose pharmacokinetics and pharmacodynamics of RWJ 676579 a specific p38 mitogen-activated protein kinase inhibitor: A first-in-human study
    Parasrampuria, DA
    de Boer, P
    Desai-Krieger, D
    Chow, AT
    Jones, CR
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (04) : 406 - 413